Form 4: CuriosityStream Director Sells Shares Under 10b5-1 Plan

CuriosityStream Inc. director Jonathan Huberman reported a planned sale of 14,116 common shares at $5 each, executed under a pre-arranged 10b5-1 plan.

Summary

• Jonathan Huberman, a director of CuriosityStream Inc. (CURI), reported the sale of 14,116 shares of common stock.
• The transaction occurred on November 20, 2025, at a price of $5 per share.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which Mr. Huberman entered into on August 13, 2025.
• Following this transaction, Mr. Huberman beneficially owns 1,210,169 shares indirectly through 211 LV LLC and 144,700 shares directly.
• Mr. Huberman is the managing member of 211 LV LLC and disclaims beneficial ownership of the securities held by the LLC beyond his pecuniary interest.

Sentiment

Score: 4

Explanation: The sale of shares by a director, even under a 10b5-1 plan, generally carries a negative sentiment as it can signal a belief that the stock is fully valued or that future upside is limited. However, the relatively small size of the sale compared to total holdings and the pre-planned nature mitigate some of the negativity.

Positives

• The sale was conducted under a pre-arranged 10b5-1 plan, indicating it was not based on new, non-public information.

Negatives

• A director selling shares, even under a 10b5-1 plan, can be perceived by the market as a negative signal regarding the company's future prospects or the stock's valuation.
• The sale price of $5 per share might indicate the director believes the current valuation is fair or high.

Risks

• Potential negative investor sentiment due to insider selling, which could put downward pressure on the stock price.

Future Outlook

No specific forward-looking statements or guidance were provided in this Form 4 filing.

Management Comments

• Mr. Huberman holds these securities indirectly as the reporting person and managing member of 211 LV LLC and may be deemed to share beneficial ownership of the securities held directly by 211 LV LLC, and disclaims any beneficial ownership of the reported securities other than to the extent of any pecuniary interest he may have therein, directly or indirectly.

Industry Context

Insider selling, even under a 10b5-1 plan, is a common occurrence. While 10b5-1 plans are designed to allow insiders to sell shares without being accused of trading on material non-public information, the market often interprets any insider selling as a potential signal that the insider believes the stock is fully valued or that future growth may be limited. This is particularly true for directors who are privy to strategic information.

Comparison to Industry Standards

• Insider selling, especially by directors, is generally viewed with caution by investors across all industries.
• While 10b5-1 plans are standard practice for managing insider stock sales and mitigating legal risks, they do not entirely negate the potential for negative market perception.
• Compared to other companies where insiders might be accumulating shares, this sale could be seen as less favorable.

Related Party Transactions

• Jonathan Huberman indirectly holds 1,210,169 shares through 211 LV LLC, where he is the managing member. He disclaims beneficial ownership beyond his pecuniary interest.

Stakeholder Impact

• Shareholders: May interpret the director's sale as a negative signal, potentially leading to decreased investor confidence and downward pressure on the stock price.

Next Steps

• No specific future actions or milestones were mentioned in this filing.

Key Dates

Recommendation

While insider selling can be a negative signal, this transaction was pre-planned under a 10b5-1 plan and represents a relatively small portion of the director's total holdings. It doesn't necessarily indicate a fundamental deterioration of the company's prospects but rather a planned liquidity event. Investors should monitor future insider activity and company performance rather than reacting solely to this single, pre-scheduled sale.

Keywords

CuriosityStream, CURI, Jonathan Huberman, insider trading, Form 4, stock sale, 10b5-1 plan, director, beneficial ownership